Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Only administrative metadata and revision notes were updated or removed; the ClinicalTrials.gov study content, eligibility criteria, outcomes, and trial timeline remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:11:45.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the page version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:44:49.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added 'Show glossary' option and a new revision notice (v3.4.0); updated capitalization of labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', while removing older variants like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:35.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision metadata updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:42:58.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section appears with the Texas site (Houston, MD Anderson Cancer Center). The page revision is updated to v3.3.3, and the old Texas Locations label along with the HHS Vulnerability Disclosure footer link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:51:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.